PANACEA ACQUISITION CORP II's ticker is PANA and the CUSIP is G6882C106. A total of 55 filers reported holding PANACEA ACQUISITION CORP II in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,556,250 | +1.7% | 250,000 | 0.0% | 0.32% | +25.1% |
| Q4 2022 | $2,512,500 | +2.3% | 250,000 | 0.0% | 0.26% | +24.5% |
| Q3 2022 | $2,456,000 | +0.7% | 250,000 | 0.0% | 0.21% | +6.7% |
| Q2 2022 | $2,440,000 | -0.0% | 250,000 | 0.0% | 0.20% | +10.2% |
| Q1 2022 | $2,441,000 | +0.7% | 250,000 | 0.0% | 0.18% | +18.8% |
| Q4 2021 | $2,425,000 | -0.7% | 250,000 | 0.0% | 0.15% | -8.0% |
| Q3 2021 | $2,443,000 | -2.4% | 250,000 | 0.0% | 0.16% | -9.0% |
| Q2 2021 | $2,504,000 | – | 250,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIT CAPITAL PARTNERS PLC | 900,000 | $9,000,000 | 3.04% |
| MYDA Advisors LLC | 600,000 | $6,009,000 | 1.50% |
| Sage Rock Capital Management LP | 382,500 | $3,831,000 | 0.50% |
| 683 Capital Management, LLC | 1,400,000 | $14,022,000 | 0.48% |
| Bain Capital Life Sciences Investors, LLC | 500,000 | $5,010,000 | 0.33% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 886,642 | $8,866,000 | 0.25% |
| Consonance Capital Management LP | 200,000 | $2,002,000 | 0.24% |
| Governors Lane LP | 250,000 | $2,504,000 | 0.18% |
| Boxer Capital, LLC | 500,000 | $5,010,000 | 0.18% |
| Greenlight Capital | 275,000 | $2,754,000 | 0.17% |